Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Surmodics Inc
(NQ:
SRDX
)
38.26
-0.16 (-0.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Surmodics Inc
< Previous
1
2
3
4
5
6
Next >
SRDX EQUITY ALERT: Rosen Law Firm Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX
January 19, 2023
From
Rosen Law Firm
Via
Business Wire
Dow Drops 150 Points; Crude Oil Up 1%
January 19, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 150 points on Thursday.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 19, 2023
On Thursday, 29 stocks made new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 19, 2023
Via
Benzinga
Surmodics Stock Slides Following Regulatory Setback For Its SurVeil Drug-Coated Balloon
January 19, 2023
Via
Benzinga
Surmodics: Q3 Earnings Insights
July 27, 2022
Surmodics (NASDAQ:SRDX) reported its Q3 earnings results on Wednesday, July 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Recap: Surmodics Q2 Earnings
April 27, 2022
Surmodics (NASDAQ:SRDX) reported its Q2 earnings results on Wednesday, April 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 19, 2023
Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.
Via
Benzinga
Nasdaq Down Over 100 Points; Procter & Gamble Posts In-Line Earnings
January 19, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 300 points on Thursday.
Via
Benzinga
Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low
January 19, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Thursday.
Via
Benzinga
Differentiated Capabilities of Surmodics’ Crystalline Drug Release Platform for Sirolimus-Coated Balloons Presented at ISET Conference
January 19, 2023
From
Surmodics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 19, 2023
Via
Benzinga
Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
January 19, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces SWING Trial 12-Month Data to be Presented at ISET Conference on January 18
January 16, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium
November 17, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16
November 11, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance
November 09, 2022
From
Surmodics, Inc.
Via
Business Wire
24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference
November 02, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on November 9th
October 28, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces TRANSCEND Trial 24-Month Data to be Presented at VIVA 2022
October 26, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces New Credit Facilities Providing up to $125 Million in Financing
October 17, 2022
From
Surmodics, Inc.
Via
Business Wire
6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe
October 11, 2022
From
Surmodics, Inc.
Via
Business Wire
6-Month Data from the Surmodics SWING First-in-Human Study to be Presented at AMP Europe
October 07, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Present at Upcoming Gilmartin Emerging Growth Company Showcase Wednesday, August 31, 2022
August 23, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports Third Quarter Fiscal 2022 Results
July 27, 2022
From
Surmodics, Inc.
Via
Business Wire
A Preview Of Surmodics's Earnings
July 26, 2022
Surmodics (NASDAQ:SRDX) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement. Analysts estimate that Surmodics will...
Via
Benzinga
Earnings Scheduled For July 27, 2022
July 27, 2022
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.
Via
Benzinga
Surmodics to Webcast Third Quarter Fiscal 2022 Earnings Conference Call on July 27
July 19, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Present at Jefferies Healthcare Conference
June 01, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports Second Quarter Fiscal 2022 Results
April 27, 2022
From
Surmodics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.